GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


INTRODUCTION TO QUANTITATIVE BENEFIT-RISK ANALYSES METHODS


OBJECTIVES

This course aims to give you an inclusive overview of the concept and scope benefit-risk evaluations of medicines, to inform you on the sources and integration of data for benefit-risk and at least to clarify the criteria for benefit-risk assessment model.

Qualitative & Quantitative B-R Measurement, Benefit-Risk Methodologies, European Medicines Agency

 

LEARNING OUTCOMES

At the end of the course, you will be able to:

  • define benefit and risk in European Medicines Agency framework

  • explain the rationale of qualitative & quantitative B-R measurement in the process decision making

  • delect and integrate appropriate data sources for BR assessment

  • classify  and group various Benefit-Risk methodologies.

 

60 minutes
Online based learning
English language
Certificate of Achievement
500 €
REGISTER NOW

AUTHOR

avatar

Prof. Olaf Klungel

Utrecht Universiteit



COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners